Victory Capital Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,765
Closed -$8.8K – 2614
2023
Q1
$8.8K Buy
1,765
+42
+2% +$266 ﹤0.01% 2552
2022
Q4
$8.32K Sell
1,723
-1
-0.1% -$5 ﹤0.01% 2550
2022
Q3
$18K Sell
1,724
-327
-16% -$4.56K ﹤0.01% 2637
2022
Q2
$29K Buy
2,051
+33
+2% +$526 ﹤0.01% 2592
2022
Q1
$34K Sell
2,018
-58
-3% -$999 ﹤0.01% 2619
2021
Q4
$51K Sell
2,076
-48
-2% -$1.51K ﹤0.01% 2640
2021
Q3
$78K Buy
2,124
+25
+1% +$918 ﹤0.01% 2650
2021
Q2
$103K Sell
2,099
-39
-2% -$1.63K ﹤0.01% 2596
2021
Q1
$63K Sell
2,138
-66
-3% -$1.85K ﹤0.01% 2650
2020
Q4
$56K Buy
2,204
+93
+4% +$1.87K ﹤0.01% 2453
2020
Q3
$31K Sell
2,111
-53
-2% -$877 ﹤0.01% 2406
2020
Q2
$45K Buy
2,164
+119
+6% +$3.15K ﹤0.01% 2403
2020
Q1
$65K Buy
+2,045
New +$51.3K ﹤0.01% 2447
2019
Q4
– Sell
-964
Closed -$14K – 3276
2019
Q3
$14K Buy
+964
New +$15.7K ﹤0.01% 3159
2018
Q4
– Sell
-17,250
Closed -$1.5M – 1814
2018
Q3
$1.5M Sell
17,250
-3,697
-18% -$368K ﹤0.01% 1169
2018
Q2
$1.73M Sell
20,947
-1,871
-8% -$115K ﹤0.01% 1107
2018
Q1
$816K Buy
+22,818
New +$884K ﹤0.01% 1278

Other funds holding VSTM

Victory Capital Management's VSTM Position: Q2 2023 in Review

Victory Capital Management sold out of Verastem (VSTM) in Q2 2023, closing a stake of 1,765 shares — an estimated $8.8K sold.

Victory Capital Management first reported a position in VSTM in Q1 2018 and held it in 17 quarters. The position peaked at $1.73M in Q2 2018. 61 funds tracked by Wall St. Rank hold VSTM as of Q2 2023.

  • Victory Capital Management reported no remaining Verastem position as of Q2 2023 after selling out during the quarter.
  • Victory Capital Management sold 1,765 Verastem shares in Q2 2023, an estimated $8.8K.
  • Victory Capital Management first reported a position in Verastem in Q1 2018 and held it in 17 quarters.
  • Victory Capital Management's Verastem position peaked at $1.73M in Q2 2018.
  • 61 funds tracked by Wall St. Rank held Verastem as of Q2 2023.

Based on Victory Capital Management's 13F filing for Q2 2023, filed 27 Jul 2023.